Co-delivery of pirfenidone and siRNA in ZIF-based nanoparticles for dual inhibition of hepatic stellate cell activation in liver fibrotic therapy

Wang, Kaili; Chen, Hao; Qin, Si; Chen, Shuhui; Zhang, Qian; Chen, Jiali; Di, Donghua; Su, Guangyue; Yuan, Yue

Co-delivery of pirfenidone and siRNA in ZIF-based nanoparticles for dual inhibition of hepatic stellate cell activation in liver fibrotic therapy

journal contribution

posted on 2024-10-19, 22:53 authored by Kaili Wang, Hao Chen, Si Qin, Shuhui Chen, Qian Zhang, Jiali Chen, Donghua Di, Guangyue Su, Yue Yuan

Co-delivery of pirfenidone and siRNA in ZIF-based nanoparticles for dual inhibition of hepatic stellate cell activation in liver fibrotic therapy

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1016/j.colsurfb.2023.113567

Location

Amsterdam, The Netherlands

Language

eng

Author URL

https://www.ncbi.nlm.nih.gov/pubmed/37797465

Publication classification

C1.1 Refereed article in a scholarly journal

Journal

Colloids and Surfaces B: Biointerfaces

Volume

231

Article number

113567

Pagination

1-10

ISSN

0927-7765

eISSN

1873-4367

Publisher

Elsevier

Publication URL

http://dx.doi.org/10.1016/j.colsurfb.2023.113567

Co-delivery of pirfenidone and siRNA in ZIF-based nanoparticles for dual inhibition of hepatic stellate cell activation in liver fibrotic therapy

History

Related Materials

Location

Language

Author URL

Publication classification

Journal

Volume

Article number

Pagination

ISSN

eISSN

Publisher

Publication URL

Usage metrics

Categories

Keywords

Licence

Exports